Literature DB >> 19383635

Neuropathogenesis and neurovirulence of live flaviviral vaccines in monkeys.

Inessa Levenbook, Ken Draper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19383635      PMCID： PMC2682093          DOI： 10.1128/JVI.02621-08

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  28 in total

1.  IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31-February 1, 2005, Geneva.

Authors: 
Journal:  Biologicals       Date:  2005-10-28       Impact factor: 1.856

2.  The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination.

Authors:  I S Levenbook; L J Pelleu; B L Elisberg
Journal:  J Biol Stand       Date:  1987-10

3.  Study of the virulence of tick-borne encephalitis virus. VI. Intracerebral infection of monkeys with clones experimentally attenuated virus.

Authors:  V Mayer; J Rajcáni
Journal:  Acta Virol       Date:  1967-07       Impact factor: 1.162

4.  Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers.

Authors:  N Nathanson; M Davis; I S Thind; W H Price
Journal:  Am J Epidemiol       Date:  1966-11       Impact factor: 4.897

5.  Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus.

Authors:  N Nathanson; I S Thind; W O'Leary; W H Price
Journal:  Am J Epidemiol       Date:  1968-07       Impact factor: 4.897

6.  Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Authors:  T P Monath; K Soike; I Levenbook; Z X Zhang; J Arroyo; S Delagrave; G Myers; A D Barrett; R E Shope; M Ratterree; T J Chambers; F Guirakhoo
Journal:  Vaccine       Date:  1999-04-09       Impact factor: 3.641

Review 7.  Viral encephalitis: a review of diagnostic methods and guidelines for management.

Authors:  I Steiner; H Budka; A Chaudhuri; M Koskiniemi; K Sainio; O Salonen; P G E Kennedy
Journal:  Eur J Neurol       Date:  2005-05       Impact factor: 6.089

8.  Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys.

Authors:  Renato S Marchevsky; Marcos S Freire; Evandro S F Coutinho; Ricardo Galler
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

9.  A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

Authors:  F Guirakhoo; Z Zhang; G Myers; B W Johnson; K Pugachev; R Nichols; N Brown; I Levenbook; K Draper; S Cyrek; J Lang; C Fournier; B Barrere; S Delagrave; T P Monath
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Authors:  F Guirakhoo; K Pugachev; Z Zhang; G Myers; I Levenbook; K Draper; J Lang; S Ocran; F Mitchell; M Parsons; N Brown; S Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; R Nichols; D Trent; T Monath
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103
View more
  2 in total

1.  High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence.

Authors:  Olga A Maximova; Brian R Murphy; Alexander G Pletnev
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

2.  Cellular inflammatory response to flaviviruses in the central nervous system of a primate host.

Authors:  Olga A Maximova; Lawrence J Faucette; Jerrold M Ward; Brian R Murphy; Alexander G Pletnev
Journal:  J Histochem Cytochem       Date:  2009-07-06       Impact factor: 2.479
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.